Intelligence · Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
Vadadustat
Akebia Europe Limited
Hepatic Impairment
1 trial -
Vadadustat
Akebia Europe Limited
Drug Interaction Potentiation
4 trials -
Vadadustat
Akebia Europe Limited
Anemia Associated With Chronic Kidney Disease
1 trial -
Vagal Nerve Stimulation
Rhythm Pharmaceuticals Netherlands B.V.
Inflammation
1 trial -
Vagus Nerve Stimulation
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Refractory Epilepsy
1 trial -
Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
Hospital Authority, Hong Kong
COVID-19 Pandemic
1 trial -
Valacyclovir
Teva Pharma GmbH
Healthy
2 trials -
Valemetostat Tosylate, DS-8201a, Datopotamab deruxtecan, Valemetostat Tosylate, Valemetostat Tosylate
Daiichi Sankyo
This study will be a Phase 1b, global, multicenter, open-label, 2-part study of valemetostat in combination with DXd ADCs. The Master Protocol study design contains independent subprotocols, which have been defined by treatment combination and subject population, as follows: Sub-protocol A: Valemetostat in combination with T-DXd in subjects with previously treated, unresectable and/or metastatic HER2-low (immunohistochemistry[IHC] 1+ or IHC 2+/in situ hybridization [ISH]-negative) BC; for details, see Sub-protocol A. Sub-protocol B: Valemetostat in combination with T-DXd in subjects with previously treated, advanced or metastatic HER2-positive gastric or GEJ adenocarcinoma; for details, see Sub-protocol B. Sub-protocol C: Valemetostat in combination with Dato-DXd in subjects with previously treated, locally advanced, unresectable, or metastatic non-squamous NSCLC with or without actionable genomic alteration(s); for details, see Sub-protocol C.
1 trial -
Vancomycin Pre-Treatment
Seres Therapeutics
Allogeneic Hematopoietic Stem Cell Transplantation
1 trial -
Vantictumab
Mereo BioPharma Group plc
Pancreatic Cancer
1 trial -
Vantictumab combined with paclitaxel
Mereo BioPharma Group plc
Metastatic Breast Cancer
1 trial -
Vanzacaftor
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Vaporized Marijuana
BRIGHT MINDS BIOSCIENCES INC.
Marijuana Usage
1 trial -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Drug Addiction
1 trial -
Varenicline Tartrate
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Addiction
1 trial -
Varenicline, then placebo
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Addiction
1 trial -
Vebicorvir (VBR)
ASSEMBLY BIOSCIENCES, INC.
Chronic Hepatitis B
1 trial -
Vedolizumab SC
Takeda
Healthy Volunteers
4 trials -
Vedolizumab SC
Takeda
Healthy
1 trial -
Vehicle to Methylprednisolone Aceponate Ointment, Methylprednisolone Aceponate Ointment, Advantan® 0,1% Salbe
Alphapharm Pty Ltd
Mild to moderate atopic dermatitis
1 trial -
Velusetrag
Theravance Biopharma Ireland Umited
Alzheimer's Disease
1 trial -
Vemurafenib Oral Tablet [Zelboraf]
Xiyuan Hospital of China Academy of Chinese Medical Sciences
BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
1 trial -
Venetoclax
Karyopharm Therapeutics Inc
Diffuse Large B-cell Lymphoma
1 trial -
Venetoclax
Kura Oncology
Acute Myeloid Leukemia
1 trial -
Venetoclax
Karyopharm Therapeutics Inc
Acute Leukemia of Ambiguous Lineage in Relapse
1 trial -
Venezuelan Equine Encephalitis DNA Vaccine
United Therapeutics Europe Ltd
Vaccine Reaction
1 trial -
Venlafaxine 25 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Venlafaxine Hydrochloride
Teva Pharma GmbH
Healthy
3 trials -
Verdinexor
Karyopharm Therapeutics Inc
Healthy
1 trial -
Vicks VapoInhaler
BRIGHT MINDS BIOSCIENCES INC.
Opiates
1 trial -
Viewing e-cigarette ads
BRIGHT MINDS BIOSCIENCES INC.
E-Cig Use
1 trial -
Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Istituto Gentili S.r.l.
Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapies.
1 trial -
Visual Sputum Suctioning System
The First People's Hospital of Lianyungang
Ineffective Airway Clearance
1 trial -
Vitamin B6-restricted diet + immunotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Solid Tumor Cancer
1 trial -
Voclosporin
Aurinia Pharmaceuticals
Volunteers
1 trial -
Volanesorsen
IONIS PHARMACEUTICALS INC
Abnormalities, Cardiovascular
1 trial -
Volasertib, low dose, d1q3w
Boehringer Ingelheim
Neoplasms
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Gastroesophageal Reflux
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Gastroesophageal Reflux Disease
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Healthy Participants
2 trials -
Vonoprazan
Phathom Pharmaceuticals
Healthy Volunteers
2 trials -
Vonoprazan ODT-1 or ODT-2 without Water
Phathom Pharmaceuticals
Healthy Volunteers
1 trial -
Vonsetamig
Regeneron UK Limited
Lupus Nephritis (LN)
1 trial -
Voriconazole 200mg
The First People's Hospital of Lianyungang
Cryptococcal Meningitis
1 trial -
Vortioxetine
Takeda
Healthy Adult Participants
1 trial -
Vortioxetine
Takeda
Healthy
1 trial -
Vortioxetine
Takeda
Severe Hepatic Impairment
1 trial -
Vyxeos
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs